Home LiteratureArticle Details
PMID: 3347355 Published · ppublish English Case Reports Journal Article Research Support, U.S. Gov't, P.H.S.

Unusual presentation of cis-platinum neuropathy.

Neurology ·Vol. 38 ·No. 3 ·1988-03-00 ·Pages 488-90

Mollman JE, Hogan WM, Glover DJ, McCluskey LF

Abstract

Symptoms and signs of cis-diamminedichloroplatinum II (DDP) neuropathy usually develop during treatment and stabilize or improve when DDP is stopped. We report three patients whose symptoms began 3 to 8 weeks after the last dose of DDP and progressed over 1 or 2 months to moderate-marked disability. The clinical picture in each was consistent with DDP neuropathy, and no other cause could be identified. Two of the patients improved over 8 and 27 months to become asymptomatic; the other died 2 months after presentation. It is important to recognize that DDP neuropathy can present after treatment has been discontinued since the clinical picture mimics the paraneoplastic dorsal root ganglionitis, which has a different prognosis.

MeSH Terms
Adult Aged Antineoplastic Combined Chemotherapy Protocols/therapeutic use Cisplatin/administration & dosage,adverse effects Cyclophosphamide/administration & dosage Doxorubicin/administration & dosage Female Foot Hand Humans Leg Middle Aged Nervous System Diseases/chemically induced Sensation/drug effects Uterine Neoplasms/drug therapy,secondary
Chemicals
Doxorubicin Cyclophosphamide Cisplatin
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Mollman J E
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia.
Hogan W M
Glover D J
McCluskey L F
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
0028-3878
Published
1988-03-00
Pages
488-90
Language
English
Region
United States
NLM ID
0401060
Subset
IM
Grants
NINDS NIH HHS · NS00563 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]